GO:1901160Tumor vs NormalRNA activityBox plot · TCGA cohorts
Across TCGA pan-cancer cohorts, RNA activity of the Primary amino compound metabolic process pathway differs between tumor and matched normal tissue in 9 of the 18 cancer types tested.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where pathway activity is lower in tumor tissue than in matched normal tissue. In most cancer types, this pathway shows higher activity in tumors, although a few cancer types, such as LIHC and CHOL, show the opposite pattern, with lower activity in tumor tissue.
LIHC, BRCA, and CHOL show the most reproducible tumor–normal differences in pathway activity.
Tumor vs normal pathway activity by lineage
Ranked by sampling consensus. Activity change represents the tumor-versus-normal difference in pathway activity on a log2 scale. Positive values indicate higher pathway activity in tumor tissue. The reported p-values are derived from the corresponding differential activity tests.